期刊文献+

高密度脂蛋白作为药物载体的研究进展及应用前景 被引量:1

原文传递
导出
摘要 目的综述高密度脂蛋白作为药物载体的研究进展及应用前景。方法以近年来的研究文献为基础,根据高密度脂蛋白的结构和代谢途径,对高密度脂蛋白作为药物载体的特性、应用研究等进行综述。结果高密度脂蛋白是人体内体积最小、密度最高的脂蛋白,具有独特的亲水性-疏水性结构、内源性可完全降解以及不被网状内皮系统识别和清除等多种作为药物载体的特性。以高密度脂蛋白为药物载体,不仅能够避免网状内皮系统的清除,克服药物水溶性和耐受性差、毒副作用强的缺陷,而且可以通过受体介导的机制选择性增加特定部位的药物浓度,增强药物的活性。结论高密度脂蛋白作为一种潜在的高效靶向性药物载体受到越来越多的重视,具有巨大的发展潜力及应用前景。
出处 《中国药学杂志》 CAS CSCD 北大核心 2009年第14期1041-1043,共3页 Chinese Pharmaceutical Journal
基金 国家重点基础研究“973”项目资助(2006CB503801)
  • 相关文献

参考文献1

二级参考文献33

  • 1Firestone RA. Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells. Bioconjug Chem 1994; 5:105-113.
  • 2de Smidt PC, van Berkel TJ. LDL-mediated drug targeting,Crit Rev Ther Drug Carrier Syst 1990; 7:99--120.
  • 3Janknegt R. Liposomal forraulations of cytotoxic drugs. Support Care Cancer 1996; 4:298-304.
  • 4Khazaeli MB, Conry RM, LoBuglio AF. Human immune response to monoclonal antibodies. J Immunother 1994; 15:42-52.
  • 5Tokui T, Kuroiwa C, Muramatsu S, Tokui Y, Sasagawa K,Ikeda T, Komai T. Plasma lipoproteins as targeting carriers to tumour tissues after administration of a lipophilic agent to mice. Biopharm Drug Dispos 1995; 16:91-103.
  • 6Hauser H, Kostner GM. Structural organization of free and esterified cholesterol in human high density lipoproteins. A 100.6 MHz 13C NMR study. Biochim Biophys Acta 1979; 573:375-381.
  • 7Samadi-Baboli M, Favre G, Canal P, Soula G. Low density lipoprotein for cytotoxic drug targeting: Improved activity of elliptinium der/vative against B16 melanoma in mice, Br J Cancer 1993; 68:319-326.
  • 8Kader A, Davis PJ, Kara M, Liu H. Drug targeting using low density lipoprotein (LDL): Physicochemical factors affecting drug loading into LDL particles. J Control Release 1998; 55:231-243.
  • 9Filipowska D, Filipowski T, Morelowska B, Kazanowska W,Laudanski T, Lapinjoki S, Akerlund M, Breeze A. Treatment of cancer patients with a low-density-lipoprotein delivery vehicle containing a cytotoxic drug. Cancer Chemother Pharmacol 1992; 29:396--400.
  • 10Pussinen PJ, Lindner H, Glatter O, Reicher H, Kostner GM,Wintersperger A, Malle E, Sattler W. Lipoprotein-associated alpha-tocopheryl-succinate inhibits cell growth and induces apoptosis in human MCF-7 and HBI-100 breast cancer cells.Biochirn Biophys Acta 2000; 1485:129-144.

共引文献11

同被引文献22

  • 1邹燕,史铁钧,宋海云.5-氨基水杨酸-聚乙二醇高分子前药的制备及其释放行为[J].化学与生物工程,2007,24(4):54-57. 被引量:4
  • 2孙庆元,于英梅,倪长军,周德,赵略.反相微乳法合成淀粉微球的研究[J].大连轻工业学院学报,2007,26(1):5-8. 被引量:17
  • 3俞丹密,肖苏尧,童春义,陈霖,刘选明.双醛淀粉纳米颗粒制备及作为药物载体的应用[J].科学通报,2007,52(12):1407-1412. 被引量:6
  • 4Eacute M, Auffan L, Eacute J, et al. Towards a definition of inorganic nanoparticles from an environmental, health and safe- ty perspective[J]. Nat Nanotechnol, 2009,4(10):634-641.
  • 5Zolnik B S, Gonzalez-Fernandez A, Sadrieh N, et al. Minire- view: nanoparticles and the immune system[J]. Endocrinology, 2010, 151 (2):458-465.
  • 6El-Sherbiny I M. Enhanced pH-responsive carrier system based on alginate and chemically modified carboxymethyl chito- san for oral delivery of protein drugs: Preparation and in-vi- tro assessment[J]. Carbohyd Polym, 2010,80(4):1125-1136.
  • 7Alishahi A, Mirvaghefi A, Tehrani M R, et al. Chitosan nanoparticle to carry vitamin C through the gastrointestinal tract and induce the non-specific immunity system of rainbow trout (Oncorhynchus mykiss)[J]. Carbohyd Polym, 2011,86 (1): 142-146.
  • 8Nikanjam M, Gibbs A R, Hunt C A, et al. Synthetic na- no-LDL with paclitaxel oleate as a targeted drug delivery ve- hicle for glioblastoma multiforme[J]. J Control Release, 2007, 124(3):163-171.
  • 9Chytil P, Etrych T, Konak C, et al. New HPMA copoly- mer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting[J]. J Control Release,2008,127 (2): 121 - 130.
  • 10Anada T, Takeda Y, Honda Y, et al. Synthesis of calcium phosphate-binding liposome for drug delivery[J]. Bioorg Med Chem Lett, 2009,19(15):4148-4150.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部